CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients

Table 3

Multivariate analysis of risk factors for aGvHD (grade > I).

Variable	Coefficient	𝑃 value	Odds ratio	95% CI
CMV infection/reactivation event within 1 year post HSCT	0.5473	0.1362	1.7286	0.8415 to 3.5509
CMV IgG in donor serum	0.0290	0.9411	1.0295	0.4762 to 2.2254
Donor-recipient HLA mismatch	0.8591	0.0421	2.3611	1.0310 to 5.4072
Unrelated donor	0.9520	0.0355	2.5909	1.0669 to 6.2921
BM as a source of cells	−0.6177	0.3090	0.5392	0.1640 to 1.7723